Search endpoint using contains returns wrong results

[seyilonge-nci]

Issue description

Making an api call to the Search endpoint using a matchType of "Contains" for query "M200" returns wrong results

ESTIMATE 20

Steps to reproduce the issue

1. Make a call to https://webapis-dev.cancer.gov/glossary/v1/Terms/search/Cancer.gov/Patient/en/M200?matchType=Contains&size=100&from=0

What's the expected result?

Return all results that contain "M200" within the termName

What's the actual result?

{
  "meta": {
    "totalResults": 3589,
    "from": 0
  },
  "results": [
    {
      "termId": 599960,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "1-methyl-d-tryptophan",
      "firstLetter": "#",
      "prettyUrlName": "1-methyl-d-tryptophan",
      "pronunciation": {
        "key": "(1-MEH-thul-d-TRIP-toh-fan)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/721195.mp3"
      },
      "definition": {
        "html": "A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT.",
        "text": "A substance being studied in the treatment of melanoma and many other types of cancer. 1-methyl-d-tryptophan blocks the breakdown of the amino acid tryptophan, which is needed for T cells (a type of immune system cell) to kill tumor cells. Giving 1-methyl-d-tryptophan to patients who have received chemotherapy for cancer may help kill more tumor cells. It is a type of enzyme inhibitor and immunosuppressant. Also called D-1MT."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 44880,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "10-propargyl-10-deazaaminopterin",
      "firstLetter": "#",
      "prettyUrlName": "10-propargyl-10-deazaaminopterin",
      "pronunciation": {
        "key": "(10-proh-PAR-jil-10-dee-AY-zuh-a-mih-NOP-teh-rin)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/728188.mp3"
      },
      "definition": {
        "html": "A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs.",
        "text": "A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called folate analogs."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 579671,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "111In-ibritumomab tiuxetan",
      "firstLetter": "#",
      "prettyUrlName": "111in-ibritumomab-tiuxetan",
      "pronunciation": {
        "key": "(... ih-brih-TOO-moh-mab ty-UK-seh-tan)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/720467.mp3"
      },
      "definition": {
        "html": "A radiolabeled\n          monoclonal antibody used to find certain types of B-cell\n          non-Hodgkin lymphoma. It is also being studied in the\n          diagnosis of other types of B-cell tumors.\n          111In-ibritumomab tiuxetan is made up of the\n          monoclonal antibody ibritumomab plus the radioisotope\n          indium In 111. It binds to a protein called CD20, which is\n          found on B cells. A machine is used to find which cells in\n          the body have taken up 111In-ibritumomab tiuxetan.\n          111In-ibritumomab tiuxetan is a type of\n          radioimmunoconjugate. Also called 111In-Zevalin and indium In 111-ibritumomab tiuxetan.",
        "text": "A radiolabeled\n          monoclonal antibody used to find certain types of B-cell\n          non-Hodgkin lymphoma. It is also being studied in the\n          diagnosis of other types of B-cell tumors.\n          111In-ibritumomab tiuxetan is made up of the\n          monoclonal antibody ibritumomab plus the radioisotope\n          indium In 111. It binds to a protein called CD20, which is\n          found on B cells. A machine is used to find which cells in\n          the body have taken up 111In-ibritumomab tiuxetan.\n          111In-ibritumomab tiuxetan is a type of\n          radioimmunoconjugate. Also called 111In-Zevalin and indium In 111-ibritumomab tiuxetan."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 736791,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "123I-MIBG",
      "firstLetter": "#",
      "prettyUrlName": "123i-mibg",
      "pronunciation": null,
      "definition": {
        "html": "A drug containing a form of radioactive iodine called I 123 that is used to find certain types of tumors, including pheochromocytomas and neuroblastomas. Radiation from I 123 may help show where cancer cells are in the body. 123I-MIBG is a type of radioconjugate. Also called AdreView, iobenguane I 123,  and iodine I 123-metaiodobenzylguanidine.",
        "text": "A drug containing a form of radioactive iodine called I 123 that is used to find certain types of tumors, including pheochromocytomas and neuroblastomas. Radiation from I 123 may help show where cancer cells are in the body. 123I-MIBG is a type of radioconjugate. Also called AdreView, iobenguane I 123,  and iodine I 123-metaiodobenzylguanidine."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 390341,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "131I-MIBG",
      "firstLetter": "#",
      "prettyUrlName": "131i-mibg",
      "pronunciation": null,
      "definition": {
        "html": "A drug containing a form of radioactive iodine called I 131 that is used to treat malignant pheochromocytoma and paraganglioma. It is used in patients who need treatment with systemic anticancer therapy and whose tumor cells take up radioactive iobenguane and are detected by a scanner. 131I-MIBG is used to treat pheochromocytoma and paraganglioma that cannot be removed by surgery, are locally advanced, or have spread to other parts of the body. It is also being studied in the treatment of other types of cancer. 131I-MIBG builds up in tumor cells and gives off radiation that may kill the tumor cells. It is a type of radioconjugate. Also called Azedra, iobenguane I 131,  and iodine I 131-metaiodobenzylguanidine.",
        "text": "A drug containing a form of radioactive iodine called I 131 that is used to treat malignant pheochromocytoma and paraganglioma. It is used in patients who need treatment with systemic anticancer therapy and whose tumor cells take up radioactive iobenguane and are detected by a scanner. 131I-MIBG is used to treat pheochromocytoma and paraganglioma that cannot be removed by surgery, are locally advanced, or have spread to other parts of the body. It is also being studied in the treatment of other types of cancer. 131I-MIBG builds up in tumor cells and gives off radiation that may kill the tumor cells. It is a type of radioconjugate. Also called Azedra, iobenguane I 131,  and iodine I 131-metaiodobenzylguanidine."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 635418,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "1572 form",
      "firstLetter": "#",
      "prettyUrlName": "1572-form",
      "pronunciation": {
        "key": "(… form)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/732881.mp3"
      },
      "definition": {
        "html": "A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial. The investigator verifies that he or she has the experience and background needed to conduct the trial and that it will be done in a way that is ethical and scientifically sound.   Also called Form FDA 1572-Statement of Investigator.",
        "text": "A form that must be filed by an investigator running a clinical trial to study a new drug or agent. The investigator agrees to follow the U.S. Food and Drug Administration (FDA) Code of Federal Regulations for the clinical trial. The investigator verifies that he or she has the experience and background needed to conduct the trial and that it will be done in a way that is ethical and scientifically sound.   Also called Form FDA 1572-Statement of Investigator."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 455147,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "17-dimethylaminoethylamino-17-demethoxygeldanamycin",
      "firstLetter": "#",
      "prettyUrlName": "17-dimethylaminoethylamino-17-demethoxygeldanamycin",
      "pronunciation": {
        "key": "(17-dy-MEH-thul-uh-MEE-noh-EH-thul-uh-MEE-noh-17-dee-meh-THOK-see-gel-DA-nuh-MY-sin)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/715227.mp3"
      },
      "definition": {
        "html": "17-DMAG. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called geldanamycin analogs.",
        "text": "17-DMAG. A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called geldanamycin analogs."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46745,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "17-N-allylamino-17-demethoxygeldanamycin",
      "firstLetter": "#",
      "prettyUrlName": "17-n-allylamino-17-demethoxygeldanamycin",
      "pronunciation": {
        "key": "(17-N-A-lul-uh-MEE-noh-17-DEE-meh-THOK-see-gel-DA-nuh-MY-sin)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/710021.mp3"
      },
      "definition": {
        "html": "A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin.",
        "text": "A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-N-allylamino-17-demethoxygeldanamycin helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-AAG and tanespimycin."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 680686,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "18F-fluoromethylcholine",
      "firstLetter": "#",
      "prettyUrlName": "18f-fluoromethylcholine",
      "pronunciation": {
        "key": "(… FLOOR-oh-MEH-thul-KOH-leen)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/727592.mp3"
      },
      "definition": {
        "html": "A radioactive substance being studied in positron emission tomography (PET) imaging to find certain types of cancer. 18F-fluoromethylcholine gets taken up by cells in the body and more of it is taken up by cancer cells than by normal cells. A PET scanner is used to find which cells in the body have taken up 18F-fluoromethylcholine. Also called 18F-choline, 18F-FMCH,  and fluorine F 18-fluoromethylcholine.",
        "text": "A radioactive substance being studied in positron emission tomography (PET) imaging to find certain types of cancer. 18F-fluoromethylcholine gets taken up by cells in the body and more of it is taken up by cancer cells than by normal cells. A PET scanner is used to find which cells in the body have taken up 18F-fluoromethylcholine. Also called 18F-choline, 18F-FMCH,  and fluorine F 18-fluoromethylcholine."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 599959,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "18F-fluoromisonidazole",
      "firstLetter": "#",
      "prettyUrlName": "18f-fluoromisonidazole",
      "pronunciation": {
        "key": "(… FLOOR-oh-MY-soh-NIH-duh-zole)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/721193.mp3"
      },
      "definition": {
        "html": "A radioactive substance being studied as an imaging agent in head and neck cancer and other types of cancer. It binds to large molecules in cancer cells that have a low level of oxygen. Radiation given off by 18F-fluoromisonidazole is detected by a positron emission tomography (PET) scan. Knowing the amount of 18F-fluoromisonidazole in the cancer cells may help plan the best treatment and help predict whether the cancer will come back after treatment. Also called 18F-MISO, fluorine F 18-fluoromisonidazole,  and FMISO.",
        "text": "A radioactive substance being studied as an imaging agent in head and neck cancer and other types of cancer. It binds to large molecules in cancer cells that have a low level of oxygen. Radiation given off by 18F-fluoromisonidazole is detected by a positron emission tomography (PET) scan. Knowing the amount of 18F-fluoromisonidazole in the cancer cells may help plan the best treatment and help predict whether the cancer will come back after treatment. Also called 18F-MISO, fluorine F 18-fluoromisonidazole,  and FMISO."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 468784,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "18F-fluorothymidine",
      "firstLetter": "#",
      "prettyUrlName": "18f-fluorothymidine",
      "pronunciation": {
        "key": "(... FLOOR-oh-THY-mih-deen)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/716811.mp3"
      },
      "definition": {
        "html": "A radioactive substance being studied in the diagnosis of cancer. 18F-fluorothymidine is injected into the blood and builds up in cells that are dividing, including cancer cells. The radiation that it gives off as it decays (breaks down) helps make clear pictures of tumors during a positron emission tomography (PET) scan. Also called 18F-FLT, 3’-deoxy-3’-(18F) fluorothymidine,  and fluorine F 18-fluorothymidine.",
        "text": "A radioactive substance being studied in the diagnosis of cancer. 18F-fluorothymidine is injected into the blood and builds up in cells that are dividing, including cancer cells. The radiation that it gives off as it decays (breaks down) helps make clear pictures of tumors during a positron emission tomography (PET) scan. Also called 18F-FLT, 3’-deoxy-3’-(18F) fluorothymidine,  and fluorine F 18-fluorothymidine."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 680688,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "18F-FMCH",
      "firstLetter": "#",
      "prettyUrlName": "18f-fmch",
      "pronunciation": null,
      "definition": {
        "html": "A radioactive substance being studied in positron emission tomography (PET) imaging to find certain types of cancer. 18F-FMCH gets taken up by cells in the body and more of it is taken up by cancer cells than by normal cells. A PET scanner is used to find which cells in the body have taken up 18F-FMCH. Also called 18F-choline, 18F-fluoromethylcholine,  and fluorine F 18-fluoromethylcholine.",
        "text": "A radioactive substance being studied in positron emission tomography (PET) imaging to find certain types of cancer. 18F-FMCH gets taken up by cells in the body and more of it is taken up by cancer cells than by normal cells. A PET scanner is used to find which cells in the body have taken up 18F-FMCH. Also called 18F-choline, 18F-fluoromethylcholine,  and fluorine F 18-fluoromethylcholine."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 599988,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "18F-MISO",
      "firstLetter": "#",
      "prettyUrlName": "18f-miso",
      "pronunciation": null,
      "definition": {
        "html": "A radioactive substance being studied as an imaging agent in head and neck cancer and other types of cancer. It binds to large molecules in cancer cells that have a low level of oxygen. Radiation given off by 18F-MISO is detected by a positron emission tomography (PET) scan. Knowing the amount of 18F-MISO in the cancer cells may help plan the best treatment and help predict whether the cancer will come back after treatment. Also called 18F-fluoromisonidazole, fluorine F 18-fluoromisonidazole,  and FMISO.",
        "text": "A radioactive substance being studied as an imaging agent in head and neck cancer and other types of cancer. It binds to large molecules in cancer cells that have a low level of oxygen. Radiation given off by 18F-MISO is detected by a positron emission tomography (PET) scan. Knowing the amount of 18F-MISO in the cancer cells may help plan the best treatment and help predict whether the cancer will come back after treatment. Also called 18F-fluoromisonidazole, fluorine F 18-fluoromisonidazole,  and FMISO."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 658784,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "18F-sodium fluoride positron emission tomography",
      "firstLetter": "#",
      "prettyUrlName": "18f-sodium-fluoride-positron-emission-tomography",
      "pronunciation": {
        "key": "(… SOH-dee-um FLOOR-ide PAH-zih-tron ee-MIH-shun toh-MAH-gruh-fee)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/726125.mp3"
      },
      "definition": {
        "html": "A procedure used to find out if cancer has spread to the bone. A small amount of a radioactive substance called 18F-sodium fluoride is injected into a vein.  A PET scan is then used to make detailed pictures of the bones. Bones with cancer in them take up more 18F-sodium fluoride than normal bones do. Also called 18F-NaF PET and fluorine F 18-sodium fluoride PET.",
        "text": "A procedure used to find out if cancer has spread to the bone. A small amount of a radioactive substance called 18F-sodium fluoride is injected into a vein.  A PET scan is then used to make detailed pictures of the bones. Bones with cancer in them take up more 18F-sodium fluoride than normal bones do. Also called 18F-NaF PET and fluorine F 18-sodium fluoride PET."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 44924,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "1H-nuclear magnetic resonance spectroscopic imaging",
      "firstLetter": "#",
      "prettyUrlName": "1h-nuclear-magnetic-resonance-spectroscopic-imaging",
      "pronunciation": {
        "key": "(... NOO-klee-er mag-NEH-tik REH-zuh-nunts SPEK-troh-SKAH-pik IH-muh-jing)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/706150.mp3"
      },
      "definition": {
        "html": "A noninvasive imaging method that provides information about cellular activity (metabolic information). It is used along with magnetic resonance imaging (MRI) which provides information about the shape and size of the tumor (spatial information). Also called magnetic resonance spectroscopic imaging, MRSI,  and proton magnetic resonance spectroscopic imaging.",
        "text": "A noninvasive imaging method that provides information about cellular activity (metabolic information). It is used along with magnetic resonance imaging (MRI) which provides information about the shape and size of the tumor (spatial information). Also called magnetic resonance spectroscopic imaging, MRSI,  and proton magnetic resonance spectroscopic imaging."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 784778,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "2-D mammography",
      "firstLetter": "#",
      "prettyUrlName": "2-d-mammography",
      "pronunciation": {
        "key": "(… ma-MAH-gruh-fee)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/789249.mp3"
      },
      "definition": {
        "html": "A procedure that uses x-rays to take pictures of the inside of the breast. The pictures are usually taken from two different angles, and a computer or x-ray film is used to make 2-D pictures of the breast. 2-D mammography is used to check for breast cancer and other changes in the breast, such as abnormal lumps, cysts, or calcifications (calcium deposits). Also called 2-dimensional mammography.",
        "text": "A procedure that uses x-rays to take pictures of the inside of the breast. The pictures are usually taken from two different angles, and a computer or x-ray film is used to make 2-D pictures of the breast. 2-D mammography is used to check for breast cancer and other changes in the breast, such as abnormal lumps, cysts, or calcifications (calcium deposits). Also called 2-dimensional mammography."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 784779,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "2-dimensional mammography",
      "firstLetter": "#",
      "prettyUrlName": "2-dimensional-mammography",
      "pronunciation": {
        "key": "(2-dih-MEN-shuh-nul ma-MAH-gruh-fee)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/789251.mp3"
      },
      "definition": {
        "html": "A procedure that uses x-rays to take pictures of the inside of the breast. The pictures are usually taken from two different angles, and a computer or x-ray film is used to make 2-D pictures of the breast. 2-dimensional mammography is used to check for breast cancer and other changes in the breast, such as abnormal lumps, cysts, or calcifications (calcium deposits). Also called 2-D mammography.",
        "text": "A procedure that uses x-rays to take pictures of the inside of the breast. The pictures are usually taken from two different angles, and a computer or x-ray film is used to make 2-D pictures of the breast. 2-dimensional mammography is used to check for breast cancer and other changes in the breast, such as abnormal lumps, cysts, or calcifications (calcium deposits). Also called 2-D mammography."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 45058,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "2-methoxyestradiol",
      "firstLetter": "#",
      "prettyUrlName": "2-methoxyestradiol",
      "pronunciation": {
        "key": "(2-meh-THOK-see-es-truh-DY-ol)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/727453.mp3"
      },
      "definition": {
        "html": "2ME2. A drug that prevents the formation of new blood vessels that tumors need in order to grow. It is derived from estrogen and belongs to the family of drugs called angiogenesis inhibitors.",
        "text": "2ME2. A drug that prevents the formation of new blood vessels that tumors need in order to grow. It is derived from estrogen and belongs to the family of drugs called angiogenesis inhibitors."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46721,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "2IT-BAD monoclonal antibody 170",
      "firstLetter": "#",
      "prettyUrlName": "2it-bad-monoclonal-antibody-170",
      "pronunciation": {
        "key": "(… MAH-noh-KLOH-nul AN-tee-BAH-dee …)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/709988.mp3"
      },
      "definition": {
        "html": "A substance being studied in the treatment of cancer. It is made by linking a monoclonal antibody called 170, which binds to a protein called MUC-1, to a substance called 2IT-BAD, which binds radioactive substances. 2IT-BAD monoclonal antibody 170 may be used to detect cancer cells and kill them. It is a type of immunoconjugate.",
        "text": "A substance being studied in the treatment of cancer. It is made by linking a monoclonal antibody called 170, which binds to a protein called MUC-1, to a substance called 2IT-BAD, which binds radioactive substances. 2IT-BAD monoclonal antibody 170 may be used to detect cancer cells and kill them. It is a type of immunoconjugate."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 658757,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "3 Tesla magnetic resonance imaging",
      "firstLetter": "#",
      "prettyUrlName": "3-tesla-magnetic-resonance-imaging",
      "pronunciation": {
        "key": "(3 TES-luh mag-NEH-tik REH-zuh-nunts IH-muh-jing)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/726096.mp3"
      },
      "definition": {
        "html": "A procedure in which radio waves and a powerful magnet linked to a computer are used to make detailed pictures of areas inside the body. These pictures can show the difference between normal and abnormal tissue. 3 Tesla magnetic resonance imaging has a stronger magnet and makes better images of organs and soft tissue than other types of MRI do. It is used to make images of the brain, the spine, the soft tissue of joints, and the inside of bones and blood vessels.  Also called 3 Tesla MRI and 3T MRI.",
        "text": "A procedure in which radio waves and a powerful magnet linked to a computer are used to make detailed pictures of areas inside the body. These pictures can show the difference between normal and abnormal tissue. 3 Tesla magnetic resonance imaging has a stronger magnet and makes better images of organs and soft tissue than other types of MRI do. It is used to make images of the brain, the spine, the soft tissue of joints, and the inside of bones and blood vessels.  Also called 3 Tesla MRI and 3T MRI."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 658756,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "3 Tesla MRI",
      "firstLetter": "#",
      "prettyUrlName": "3-tesla-mri",
      "pronunciation": {
        "key": "(3 TES-luh …)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/726480.mp3"
      },
      "definition": {
        "html": "A procedure in which radio waves and a powerful magnet linked to a computer are used to make detailed pictures of areas inside the body. These pictures can show the difference between normal and abnormal tissue. 3 Tesla MRI has a stronger magnet and makes better images of organs and soft tissue than other types of MRI do. It is used to make images of the brain, the spine, the soft tissue of joints, and the inside of bones and blood vessels.  Also called 3 Tesla magnetic resonance imaging and 3T MRI.",
        "text": "A procedure in which radio waves and a powerful magnet linked to a computer are used to make detailed pictures of areas inside the body. These pictures can show the difference between normal and abnormal tissue. 3 Tesla MRI has a stronger magnet and makes better images of organs and soft tissue than other types of MRI do. It is used to make images of the brain, the spine, the soft tissue of joints, and the inside of bones and blood vessels.  Also called 3 Tesla magnetic resonance imaging and 3T MRI."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 597239,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "3’-deoxy-3’-(18F) fluorothymidine",
      "firstLetter": "#",
      "prettyUrlName": "3-deoxy-3-18f-fluorothymidine",
      "pronunciation": {
        "key": "(… dee-OK-see … FLOOR-oh-THY-mih-deen)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/721000.mp3"
      },
      "definition": {
        "html": "A radioactive substance being studied in the diagnosis of cancer. 3’-deoxy-3’-(18F) fluorothymidine is injected into the blood and builds up in cells that are dividing, including cancer cells. The radiation that it gives off as it decays (breaks down) helps make clear pictures of tumors during a positron emission tomography (PET) scan. Also called 18F-FLT, 18F-fluorothymidine,  and fluorine F 18-fluorothymidine.",
        "text": "A radioactive substance being studied in the diagnosis of cancer. 3’-deoxy-3’-(18F) fluorothymidine is injected into the blood and builds up in cells that are dividing, including cancer cells. The radiation that it gives off as it decays (breaks down) helps make clear pictures of tumors during a positron emission tomography (PET) scan. Also called 18F-FLT, 18F-fluorothymidine,  and fluorine F 18-fluorothymidine."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 44850,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "3-aminopyridine-2-carboxaldehyde thiosemicarbazone",
      "firstLetter": "#",
      "prettyUrlName": "3-aminopyridine-2-carboxaldehyde-thiosemicarbazone",
      "pronunciation": {
        "key": "(3-uh-MEE-noh-PEER-ih-deen-2-KAR-bok-SAL-deh-hide THY-oh-SEH-mee KAR-buh-ZONE)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/706069.mp3"
      },
      "definition": {
        "html": "A substance being studied in the treatment of cancer. It is a type of ribonucleotide reductase inhibitor. Also called 3-AP and Triapine.",
        "text": "A substance being studied in the treatment of cancer. It is a type of ribonucleotide reductase inhibitor. Also called 3-AP and Triapine."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 784781,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "3-D mammography",
      "firstLetter": "#",
      "prettyUrlName": "3-d-mammography",
      "pronunciation": {
        "key": "(… ma-MAH-gruh-fee)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/789253.mp3"
      },
      "definition": {
        "html": "A procedure that uses x-rays to take a series of pictures of the inside of the breast from many different angles. A computer is used to make 3-D pictures of the breast from these x-rays. 3-D mammography is used to check for breast cancer and other changes in the breast, such as abnormal lumps, cysts, or calcifications (calcium deposits). It may allow doctors to see breast tissue, including dense breast tissue, more clearly than with 2-D mammography. This may make breast tumors or other changes in the breast easier to find. Also called 3-dimensional mammography and breast tomosynthesis.",
        "text": "A procedure that uses x-rays to take a series of pictures of the inside of the breast from many different angles. A computer is used to make 3-D pictures of the breast from these x-rays. 3-D mammography is used to check for breast cancer and other changes in the breast, such as abnormal lumps, cysts, or calcifications (calcium deposits). It may allow doctors to see breast tissue, including dense breast tissue, more clearly than with 2-D mammography. This may make breast tumors or other changes in the breast easier to find. Also called 3-dimensional mammography and breast tomosynthesis."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 45582,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "3-dimensional",
      "firstLetter": "#",
      "prettyUrlName": "3-dimensional",
      "pronunciation": {
        "key": "(3-dih-MEN-shuh-nul)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/731107.mp3"
      },
      "definition": {
        "html": "A graphic display of depth, width, and height. Also called 3-D.",
        "text": "A graphic display of depth, width, and height. Also called 3-D."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 270731,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "3-dimensional conformal radiation therapy",
      "firstLetter": "#",
      "prettyUrlName": "3-dimensional-conformal-radiation-therapy",
      "pronunciation": {
        "key": "(3-dih-MEN-shuh-nul kun-FOR-mul RAY-dee-AY-shun THAYR-uh-pee)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/710233.mp3"
      },
      "definition": {
        "html": "A procedure that uses a computer to create a 3-dimensional picture of the tumor. This allows doctors to give the highest possible dose of radiation to the tumor, while sparing the normal tissue as much as possible. Also called 3-dimensional radiation therapy and 3D-CRT.",
        "text": "A procedure that uses a computer to create a 3-dimensional picture of the tumor. This allows doctors to give the highest possible dose of radiation to the tumor, while sparing the normal tissue as much as possible. Also called 3-dimensional radiation therapy and 3D-CRT."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 784782,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "3-dimensional mammography",
      "firstLetter": "#",
      "prettyUrlName": "3-dimensional-mammography",
      "pronunciation": {
        "key": "(3-dih-MEN-shuh-nul ma-MAH-gruh-fee)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/789255.mp3"
      },
      "definition": {
        "html": "A procedure that uses x-rays to take a series of pictures of the inside of the breast from many different angles. A computer is used to make 3-D pictures of the breast from these x-rays. 3-dimensional mammography is used to check for breast cancer and other changes in the breast, such as abnormal lumps, cysts, or calcifications (calcium deposits). It may allow doctors to see breast tissue, including dense breast tissue, more clearly than with 2-D mammography. This may make breast tumors or other changes in the breast easier to find. Also called 3-D mammography and breast tomosynthesis.",
        "text": "A procedure that uses x-rays to take a series of pictures of the inside of the breast from many different angles. A computer is used to make 3-D pictures of the breast from these x-rays. 3-dimensional mammography is used to check for breast cancer and other changes in the breast, such as abnormal lumps, cysts, or calcifications (calcium deposits). It may allow doctors to see breast tissue, including dense breast tissue, more clearly than with 2-D mammography. This may make breast tumors or other changes in the breast easier to find. Also called 3-D mammography and breast tomosynthesis."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 44487,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "3-dimensional radiation therapy",
      "firstLetter": "#",
      "prettyUrlName": "3-dimensional-radiation-therapy",
      "pronunciation": {
        "key": "(3-dih-MEN-shuh-nul RAY-dee-AY-shun THAYR-uh-pee)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/704646.mp3"
      },
      "definition": {
        "html": "A procedure that uses a computer to create a 3-dimensional picture of the tumor. This allows doctors to give the highest possible dose of radiation to the tumor, while sparing the normal tissue as much as possible. Also called 3-dimensional conformal radiation therapy and 3D-CRT.",
        "text": "A procedure that uses a computer to create a 3-dimensional picture of the tumor. This allows doctors to give the highest possible dose of radiation to the tumor, while sparing the normal tissue as much as possible. Also called 3-dimensional conformal radiation therapy and 3D-CRT."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 658758,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "3T MRI",
      "firstLetter": "#",
      "prettyUrlName": "3t-mri",
      "pronunciation": null,
      "definition": {
        "html": "A procedure in which radio waves and a powerful magnet linked to a computer are used to make detailed pictures of areas inside the body. These pictures can show the difference between normal and abnormal tissue. 3T MRI has a stronger magnet and makes better images of organs and soft tissue than other types of MRI do. It is used to make images of the brain, the spine, the soft tissue of joints, and the inside of bones and blood vessels.  Also called 3 Tesla magnetic resonance imaging and 3 Tesla MRI.",
        "text": "A procedure in which radio waves and a powerful magnet linked to a computer are used to make detailed pictures of areas inside the body. These pictures can show the difference between normal and abnormal tissue. 3T MRI has a stronger magnet and makes better images of organs and soft tissue than other types of MRI do. It is used to make images of the brain, the spine, the soft tissue of joints, and the inside of bones and blood vessels.  Also called 3 Tesla magnetic resonance imaging and 3 Tesla MRI."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 44413,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "4-demethoxydaunorubicin",
      "firstLetter": "#",
      "prettyUrlName": "4-demethoxydaunorubicin",
      "pronunciation": {
        "key": "(4-DEE-meh-THOK-see-DAW-noh-ROO-bih-sin)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/704576.mp3"
      },
      "definition": {
        "html": "A drug used with other drugs to treat acute myelogenous leukemia (AML). It is also being studied in the treatment of other types of cancer. 4-demethoxydaunorubicin blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. It is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called Idamycin PFS and idarubicin hydrochloride.",
        "text": "A drug used with other drugs to treat acute myelogenous leukemia (AML). It is also being studied in the treatment of other types of cancer. 4-demethoxydaunorubicin blocks a certain enzyme needed for cell division and DNA repair, and it may kill cancer cells. It is a type of anthracycline antibiotic and a type of topoisomerase inhibitor. Also called Idamycin PFS and idarubicin hydrochloride."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 386195,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "4-hydroxytamoxifen",
      "firstLetter": "#",
      "prettyUrlName": "4-hydroxytamoxifen",
      "pronunciation": {
        "key": "(4-hy-DROK-see-tuh-MOK-sih-FEN)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/731459.mp3"
      },
      "definition": {
        "html": "A form of the drug tamoxifen that is made by the body after taking tamoxifen. It can also be made in the laboratory, and may help decrease breast density. A topical form of 4-hydroxytamoxifen is being studied in breast cancer screening.",
        "text": "A form of the drug tamoxifen that is made by the body after taking tamoxifen. It can also be made in the laboratory, and may help decrease breast density. A topical form of 4-hydroxytamoxifen is being studied in breast cancer screening."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 662493,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "5-FU-leucovorin calcium",
      "firstLetter": "#",
      "prettyUrlName": "5-fu-leucovorin-calcium",
      "pronunciation": {
        "key": "(… LOO-koh-VOR-in KAL-see-um)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/798063.mp3"
      },
      "definition": {
        "html": "A chemotherapy combination used to treat colorectal cancer. It is also used with radiation therapy to treat esophageal cancer and stomach cancer. It includes the drugs fluorouracil and leucovorin calcium. Also called 5-FU-leucovorin calcium regimen.",
        "text": "A chemotherapy combination used to treat colorectal cancer. It is also used with radiation therapy to treat esophageal cancer and stomach cancer. It includes the drugs fluorouracil and leucovorin calcium. Also called 5-FU-leucovorin calcium regimen."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 662494,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "5-FU-leucovorin calcium regimen",
      "firstLetter": "#",
      "prettyUrlName": "5-fu-leucovorin-calcium-regimen",
      "pronunciation": {
        "key": "(… LOO-koh-VOR-in KAL-see-um REH-jih-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/725947.mp3"
      },
      "definition": {
        "html": "A chemotherapy combination used to treat colorectal cancer. It is also used with radiation therapy to treat esophageal cancer and stomach cancer. It includes the drugs fluorouracil and leucovorin calcium. Also called 5-FU-leucovorin calcium.",
        "text": "A chemotherapy combination used to treat colorectal cancer. It is also used with radiation therapy to treat esophageal cancer and stomach cancer. It includes the drugs fluorouracil and leucovorin calcium. Also called 5-FU-leucovorin calcium."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 335512,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "5-hydroxytryptamine",
      "firstLetter": "#",
      "prettyUrlName": "5-hydroxytryptamine",
      "pronunciation": {
        "key": "(5-hy-DROK-see-TRIP-tuh-meen)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/711264.mp3"
      },
      "definition": {
        "html": "A hormone found in the brain, platelets, digestive tract, and pineal gland. It acts both as a neurotransmitter (a substance that nerves use to send messages to one another) and a vasoconstrictor (a substance that causes blood vessels to narrow). A lack of 5-hydroxytryptamine in the brain is thought to be a cause of depression. Also called serotonin.",
        "text": "A hormone found in the brain, platelets, digestive tract, and pineal gland. It acts both as a neurotransmitter (a substance that nerves use to send messages to one another) and a vasoconstrictor (a substance that causes blood vessels to narrow). A lack of 5-hydroxytryptamine in the brain is thought to be a cause of depression. Also called serotonin."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 486388,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "5-hydroxytryptamine 3 receptor antagonist",
      "firstLetter": "#",
      "prettyUrlName": "5-hydroxytryptamine-3-receptor-antagonist",
      "pronunciation": {
        "key": "(5-hy-DROK-see-TRIP-tuh-meen 3 reh-SEP-ter an-TA-guh-nist)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/718809.mp3"
      },
      "definition": {
        "html": "A type of drug used to treat certain types of irritable bowel syndrome and relieve nausea and vomiting. It is a type of antiemetic. Also called 5-HT3 receptor antagonist and type 3 serotonin receptor antagonist.",
        "text": "A type of drug used to treat certain types of irritable bowel syndrome and relieve nausea and vomiting. It is a type of antiemetic. Also called 5-HT3 receptor antagonist and type 3 serotonin receptor antagonist."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 531047,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "5q minus syndrome",
      "firstLetter": "#",
      "prettyUrlName": "5q-minus-syndrome",
      "pronunciation": {
        "key": "(... MY-nus SIN-drome)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/718222.mp3"
      },
      "definition": {
        "html": "A rare disorder caused by loss of part of the long arm (q arm) of human chromosome 5. This syndrome affects myeloid (bone marrow) cells, causing treatment-resistant anemia and myelodysplastic syndromes that may lead to acute myelogenous leukemia. Also called 5q- syndrome.",
        "text": "A rare disorder caused by loss of part of the long arm (q arm) of human chromosome 5. This syndrome affects myeloid (bone marrow) cells, causing treatment-resistant anemia and myelodysplastic syndromes that may lead to acute myelogenous leukemia. Also called 5q- syndrome."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 44810,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "5q- syndrome",
      "firstLetter": "#",
      "prettyUrlName": "5q--syndrome",
      "pronunciation": {
        "key": "(... SIN-drome)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/706001.mp3"
      },
      "definition": {
        "html": "A rare disorder caused by loss of part of the long arm (q arm) of human chromosome 5. This syndrome affects myeloid (bone marrow) cells, causing treatment-resistant anemia and myelodysplastic syndromes that may lead to acute myelogenous leukemia. Also called 5q minus syndrome.",
        "text": "A rare disorder caused by loss of part of the long arm (q arm) of human chromosome 5. This syndrome affects myeloid (bone marrow) cells, causing treatment-resistant anemia and myelodysplastic syndromes that may lead to acute myelogenous leukemia. Also called 5q minus syndrome."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 43967,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "6-hydroxymethylacylfulvene",
      "firstLetter": "#",
      "prettyUrlName": "6-hydroxymethylacylfulvene",
      "pronunciation": {
        "key": "(6-hy-DROK-see-MEH-thul-AY-sel-FUL-veen)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/703961.mp3"
      },
      "definition": {
        "html": "A substance being studied in the treatment of some types of cancer. 6-hydroxymethylacylfulvene attaches to the cell's DNA and may block cancer cell growth. It is a type of alkylating agent. Also called irofulven.",
        "text": "A substance being studied in the treatment of some types of cancer. 6-hydroxymethylacylfulvene attaches to the cell's DNA and may block cancer cell growth. It is a type of alkylating agent. Also called irofulven."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 579676,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "90Y-ibritumomab tiuxetan",
      "firstLetter": "#",
      "prettyUrlName": "90y-ibritumomab-tiuxetan",
      "pronunciation": {
        "key": "(... ih-brih-TOO-moh-mab ty-UK-seh-tan)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/720471.mp3"
      },
      "definition": {
        "html": "A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of B-cell tumors. 90Y-ibritumomab tiuxetan contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. 90Y-ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called 90Y-Zevalin, IDEC-Y2B8,  and yttrium Y 90-ibritumomab tiuxetan.",
        "text": "A drug used with the drug rituximab to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of B-cell tumors. 90Y-ibritumomab tiuxetan contains a monoclonal antibody that binds to a protein called CD20, which is found on B cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. 90Y-ibritumomab tiuxetan is a type of radioimmunoconjugate. Also called 90Y-Zevalin, IDEC-Y2B8,  and yttrium Y 90-ibritumomab tiuxetan."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 674713,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "99m-Tc-Dx",
      "firstLetter": "#",
      "prettyUrlName": "99m-tc-dx",
      "pronunciation": null,
      "definition": {
        "html": "A substance being studied as a way to find sentinel lymph nodes in some types of skin cancer and breast cancer. It contains a radioactive substance called technetium linked to a substance called dextran.  Dextran helps technetium stay in blood and lymph vessels after it is injected. A machine or probe that detects radioactivity shows which lymph nodes near the tumor have 99m-Tc-Dx in them. Also called Tc-99m Dextran and technetium Tc 99m-dextran.",
        "text": "A substance being studied as a way to find sentinel lymph nodes in some types of skin cancer and breast cancer. It contains a radioactive substance called technetium linked to a substance called dextran.  Dextran helps technetium stay in blood and lymph vessels after it is injected. A machine or probe that detects radioactivity shows which lymph nodes near the tumor have 99m-Tc-Dx in them. Also called Tc-99m Dextran and technetium Tc 99m-dextran."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 45070,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "abdomen",
      "firstLetter": "a",
      "prettyUrlName": "abdomen",
      "pronunciation": {
        "key": "(AB-doh-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/704957.mp3"
      },
      "definition": {
        "html": "The area of the body that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs.",
        "text": "The area of the body that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46684,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "abdominal",
      "firstLetter": "a",
      "prettyUrlName": "abdominal",
      "pronunciation": {
        "key": "(ab-DAH-mih-nul)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/731719.mp3"
      },
      "definition": {
        "html": "Having to do with the abdomen, which is the part of the body between the chest and the hips that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs.",
        "text": "Having to do with the abdomen, which is the part of the body between the chest and the hips that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 649619,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "abdominal ultrasound",
      "firstLetter": "a",
      "prettyUrlName": "abdominal-ultrasound",
      "pronunciation": {
        "key": "(ab-DAH-mih-nul UL-truh-sownd)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/725697.mp3"
      },
      "definition": {
        "html": "A procedure used to examine the organs in the abdomen. An ultrasound transducer (probe) is pressed firmly against the skin of the abdomen. High-energy sound waves from the transducer bounce off tissues and create echoes. The echoes are sent to a computer, which makes a picture called a sonogram. Also called transabdominal ultrasound.",
        "text": "A procedure used to examine the organs in the abdomen. An ultrasound transducer (probe) is pressed firmly against the skin of the abdomen. High-energy sound waves from the transducer bounce off tissues and create echoes. The echoes are sent to a computer, which makes a picture called a sonogram. Also called transabdominal ultrasound."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 455670,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "abdominal x-ray",
      "firstLetter": "a",
      "prettyUrlName": "abdominal-x-ray",
      "pronunciation": {
        "key": "(ab-DAH-mih-nul EX-ray)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/715234.mp3"
      },
      "definition": {
        "html": "An x-ray of the organs inside the abdomen. An x-ray is a type of radiation that can pass through the body and onto film, making pictures of areas inside the body. X-rays may be used to help diagnose disease.",
        "text": "An x-ray of the organs inside the abdomen. An x-ray is a type of radiation that can pass through the body and onto film, making pictures of areas inside the body. X-rays may be used to help diagnose disease."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 377733,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "abdominoperineal resection",
      "firstLetter": "a",
      "prettyUrlName": "abdominoperineal-resection",
      "pronunciation": {
        "key": "(ab-DAH-mih-noh-PAYR-ih-NEE-ul ree-SEK-shun)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/713471.mp3"
      },
      "definition": {
        "html": "Surgery to remove the anus, the rectum, and part of the sigmoid colon through an incision made in the abdomen. The end of the intestine is attached to an opening in the surface of the abdomen and body waste is collected in a disposable bag outside of the body. This opening is called a colostomy. Lymph nodes that contain cancer may also be removed during this operation.",
        "text": "Surgery to remove the anus, the rectum, and part of the sigmoid colon through an incision made in the abdomen. The end of the intestine is attached to an opening in the surface of the abdomen and body waste is collected in a disposable bag outside of the body. This opening is called a colostomy. Lymph nodes that contain cancer may also be removed during this operation."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 791149,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "abemaciclib",
      "firstLetter": "a",
      "prettyUrlName": "abemaciclib",
      "pronunciation": {
        "key": "(uh-BEH-muh-SY-klib)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/792245.mp3"
      },
      "definition": {
        "html": "A drug used to treat hormone-receptor positive (HR+), HER2-negative (HER2-) breast cancer that is advanced or has spread to other parts of the body. It is used with an aromatase inhibitor in postmenopausal women who have not been treated with hormone therapy. It is used with fulvestrant in women whose disease got worse after treatment with hormone therapy. Abemaciclib is also used alone in men and women whose disease got worse after treatment with hormone therapy and previous chemotherapy. It is also being studied in the treatment of other types of cancer. Abemaciclib blocks certain proteins, which may help keep cancer cells from growing. It is a type of cyclin-dependent kinase inhibitor. Also called Verzenio.",
        "text": "A drug used to treat hormone-receptor positive (HR+), HER2-negative (HER2-) breast cancer that is advanced or has spread to other parts of the body. It is used with an aromatase inhibitor in postmenopausal women who have not been treated with hormone therapy. It is used with fulvestrant in women whose disease got worse after treatment with hormone therapy. Abemaciclib is also used alone in men and women whose disease got worse after treatment with hormone therapy and previous chemotherapy. It is also being studied in the treatment of other types of cancer. Abemaciclib blocks certain proteins, which may help keep cancer cells from growing. It is a type of cyclin-dependent kinase inhibitor. Also called Verzenio."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 44636,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "abnormal",
      "firstLetter": "a",
      "prettyUrlName": "abnormal",
      "pronunciation": {
        "key": "(ab-NOR-mul)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/704875.mp3"
      },
      "definition": {
        "html": "Not normal. Describes a state, condition, or behavior that is unusual or different from what is considered normal. An abnormal lesion or growth in or on the body may be benign (not cancer), precancerous or premalignant (likely to become cancer), or malignant (cancer).",
        "text": "Not normal. Describes a state, condition, or behavior that is unusual or different from what is considered normal. An abnormal lesion or growth in or on the body may be benign (not cancer), precancerous or premalignant (likely to become cancer), or malignant (cancer)."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 650886,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "ABO blood group system",
      "firstLetter": "a",
      "prettyUrlName": "abo-blood-group-system",
      "pronunciation": {
        "key": "(… blud groop SIS-tem)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/726419.mp3"
      },
      "definition": {
        "html": "A system used to group human blood into different types, based on the presence or absence of certain markers on the surface of red blood cells. The four main blood types are A, B, O, and AB.  For a blood transfusion, the ABO blood group system is used to match the blood type of the donor and the person receiving the transfusion. People with blood type O can donate blood to anyone and are called universal donors. People with blood type AB can accept blood from all donors and are called universal recipients. People with type A or B can receive matching blood or type O blood.",
        "text": "A system used to group human blood into different types, based on the presence or absence of certain markers on the surface of red blood cells. The four main blood types are A, B, O, and AB.  For a blood transfusion, the ABO blood group system is used to match the blood type of the donor and the person receiving the transfusion. People with blood type O can donate blood to anyone and are called universal donors. People with blood type AB can accept blood from all donors and are called universal recipients. People with type A or B can receive matching blood or type O blood."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 785688,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "Abrikossoff tumor",
      "firstLetter": "a",
      "prettyUrlName": "abrikossoff-tumor",
      "pronunciation": {
        "key": "(AH-bree-KAH-sof TOO-mer)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/789268.mp3"
      },
      "definition": {
        "html": "A rare type of soft tissue tumor that usually begins in Schwann cells (cells that hold nerve cells in place). It can occur anywhere in the body, but it usually occurs in or under the skin of the head and neck (especially the mouth or tongue). It may also occur in the chest, breast, esophagus, stomach, or other internal organ. Most Abrikossoff tumors are benign (not cancer), but some may be malignant (cancer) and spread quickly to nearby tissue. They usually occur in middle-aged adults. Also called granular cell tumor.",
        "text": "A rare type of soft tissue tumor that usually begins in Schwann cells (cells that hold nerve cells in place). It can occur anywhere in the body, but it usually occurs in or under the skin of the head and neck (especially the mouth or tongue). It may also occur in the chest, breast, esophagus, stomach, or other internal organ. Most Abrikossoff tumors are benign (not cancer), but some may be malignant (cancer) and spread quickly to nearby tissue. They usually occur in middle-aged adults. Also called granular cell tumor."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 635679,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "ABVD regimen",
      "firstLetter": "a",
      "prettyUrlName": "abvd-regimen",
      "pronunciation": {
        "key": "(… REH-jih-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/722822.mp3"
      },
      "definition": {
        "html": "An abbreviation for a chemotherapy combination used to treat Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vinblastine sulfate, and dacarbazine. Also called ABVD.",
        "text": "An abbreviation for a chemotherapy combination used to treat Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vinblastine sulfate, and dacarbazine. Also called ABVD."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 662472,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "ABVE regimen",
      "firstLetter": "a",
      "prettyUrlName": "abve-regimen",
      "pronunciation": {
        "key": "(… REH-jih-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/725931.mp3"
      },
      "definition": {
        "html": "An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes  the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, and etoposide. Also called ABVE, DBVE,  and DBVE regimen.",
        "text": "An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes  the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, and etoposide. Also called ABVE, DBVE,  and DBVE regimen."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 683641,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "ABVE-PC regimen",
      "firstLetter": "a",
      "prettyUrlName": "abve-pc-regimen",
      "pronunciation": {
        "key": "(… REH-jih-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/728063.mp3"
      },
      "definition": {
        "html": "An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide. Also called ABVE-PC, DBVE-PC,  and DBVE-PC regimen.",
        "text": "An abbreviation for a chemotherapy combination used with radiation therapy to treat childhood Hodgkin lymphoma. It includes the drugs doxorubicin hydrochloride (Adriamycin), bleomycin sulfate, vincristine sulfate, etoposide, prednisone, and cyclophosphamide. Also called ABVE-PC, DBVE-PC,  and DBVE-PC regimen."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 662445,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "AC regimen",
      "firstLetter": "a",
      "prettyUrlName": "ac-regimen",
      "pronunciation": {
        "key": "(… REH-jih-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/725907.mp3"
      },
      "definition": {
        "html": "An abbreviation for a chemotherapy combination used with other types of therapy to treat breast cancer, including breast cancer that has spread or come back. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide. Also called AC.",
        "text": "An abbreviation for a chemotherapy combination used with other types of therapy to treat breast cancer, including breast cancer that has spread or come back. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide. Also called AC."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 635683,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "AC-T regimen",
      "firstLetter": "a",
      "prettyUrlName": "ac-t-regimen",
      "pronunciation": {
        "key": "(… REH-jih-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/722825.mp3"
      },
      "definition": {
        "html": "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol). Also called AC-T and AC-Taxol regimen.",
        "text": "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol). Also called AC-T and AC-Taxol regimen."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 635690,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "AC-T-T regimen",
      "firstLetter": "a",
      "prettyUrlName": "ac-t-t-regimen",
      "pronunciation": {
        "key": "(… REH-jih-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/722829.mp3"
      },
      "definition": {
        "html": "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin). Also called AC-T-T, AC-TH regimen,  and sequential AC/Taxol-Trastuzumab regimen.",
        "text": "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin). Also called AC-T-T, AC-TH regimen,  and sequential AC/Taxol-Trastuzumab regimen."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 635684,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "AC-Taxol regimen",
      "firstLetter": "a",
      "prettyUrlName": "ac-taxol-regimen",
      "pronunciation": {
        "key": "(… TAK-sol REH-jih-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/722827.mp3"
      },
      "definition": {
        "html": "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol). Also called AC-T and AC-T regimen.",
        "text": "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol). Also called AC-T and AC-T regimen."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 635692,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "AC-TH regimen",
      "firstLetter": "a",
      "prettyUrlName": "ac-th-regimen",
      "pronunciation": {
        "key": "(… REH-jih-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/722833.mp3"
      },
      "definition": {
        "html": "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin). Also called AC-T-T, AC-T-T regimen,  and sequential AC/Taxol-Trastuzumab regimen.",
        "text": "An abbreviation for a chemotherapy combination used to treat breast cancer. It includes the drugs doxorubicin hydrochloride (Adriamycin) and cyclophosphamide, followed by treatment with paclitaxel (Taxol) and trastuzumab (Herceptin). Also called AC-T-T, AC-T-T regimen,  and sequential AC/Taxol-Trastuzumab regimen."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46212,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "accelerated phase chronic myelogenous leukemia",
      "firstLetter": "a",
      "prettyUrlName": "accelerated-phase-chronic-myelogenous-leukemia",
      "pronunciation": {
        "key": "(ak-SEH-leh-ray-ted fayz KRAH-nik MY-eh-LAH-jeh-nus loo-KEE-mee-uh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/707838.mp3"
      },
      "definition": {
        "html": "A phase of chronic myelogenous leukemia in which the disease is progressing. In this phase, 10% to 19% of the cells in the blood and bone marrow are blast cells (immature blood cells).",
        "text": "A phase of chronic myelogenous leukemia in which the disease is progressing. In this phase, 10% to 19% of the cells in the blood and bone marrow are blast cells (immature blood cells)."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 45165,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acetaminophen",
      "firstLetter": "a",
      "prettyUrlName": "acetaminophen",
      "pronunciation": {
        "key": "(uh-see-tuh-MIH-nuh-fen)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/705107.mp3"
      },
      "definition": {
        "html": "A drug that reduces pain and fever (but not inflammation). It belongs to the family of drugs called analgesics.",
        "text": "A drug that reduces pain and fever (but not inflammation). It belongs to the family of drugs called analgesics."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 643000,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acid-base equilibrium",
      "firstLetter": "a",
      "prettyUrlName": "acid-base-equilibrium",
      "pronunciation": {
        "key": "(A-sid-bays EE-kwuh-LIH-bree-um)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/723220.mp3"
      },
      "definition": {
        "html": "In medicine, the state of having the right amount of acid and base in the blood and other body fluids. Keeping a normal acid-base equilibrium is important for the body to work the way it should. Also called acid-base balance.",
        "text": "In medicine, the state of having the right amount of acid and base in the blood and other body fluids. Keeping a normal acid-base equilibrium is important for the body to work the way it should. Also called acid-base balance."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 797637,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acneiform dermatitis",
      "firstLetter": "a",
      "prettyUrlName": "acneiform-dermatitis",
      "pronunciation": {
        "key": "(ak-NEE-ih-form DER-muh-TY-tis)",
        "audio": null
      },
      "definition": {
        "html": "A skin condition that causes small, raised, acne-like bumps to form, usually on the face, scalp, chest, and upper back. The bumps on the affected skin are usually red and filled with pus and may crust over. They may also become painful, tender, and itchy. Sometimes, the affected skin becomes infected. Acneiform dermatitis may be caused by an infection or by treatment with certain drugs, including some anticancer drugs, such as  epidermal growth factor receptor (EGFR) inhibitors. Also called acneiform eruption and acneiform rash.",
        "text": "A skin condition that causes small, raised, acne-like bumps to form, usually on the face, scalp, chest, and upper back. The bumps on the affected skin are usually red and filled with pus and may crust over. They may also become painful, tender, and itchy. Sometimes, the affected skin becomes infected. Acneiform dermatitis may be caused by an infection or by treatment with certain drugs, including some anticancer drugs, such as  epidermal growth factor receptor (EGFR) inhibitors. Also called acneiform eruption and acneiform rash."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 797639,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acneiform eruption",
      "firstLetter": "a",
      "prettyUrlName": "acneiform-eruption",
      "pronunciation": {
        "key": "(ak-NEE-ih-form ee-RUP-shun)",
        "audio": null
      },
      "definition": {
        "html": "A skin condition that causes small, raised, acne-like bumps to form, usually on the face, scalp, chest, and upper back. The bumps on the affected skin are usually red and filled with pus and may crust over. They may also become painful, tender, and itchy. Sometimes, the affected skin becomes infected. Acneiform eruption may be caused by an infection or by treatment with certain drugs, including some anticancer drugs, such as  epidermal growth factor receptor (EGFR) inhibitors. Also called acneiform dermatitis and acneiform rash.",
        "text": "A skin condition that causes small, raised, acne-like bumps to form, usually on the face, scalp, chest, and upper back. The bumps on the affected skin are usually red and filled with pus and may crust over. They may also become painful, tender, and itchy. Sometimes, the affected skin becomes infected. Acneiform eruption may be caused by an infection or by treatment with certain drugs, including some anticancer drugs, such as  epidermal growth factor receptor (EGFR) inhibitors. Also called acneiform dermatitis and acneiform rash."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 797638,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acneiform rash",
      "firstLetter": "a",
      "prettyUrlName": "acneiform-rash",
      "pronunciation": {
        "key": "(ak-NEE-ih-form …)",
        "audio": null
      },
      "definition": {
        "html": "A skin condition that causes small, raised, acne-like bumps to form, usually on the face, scalp, chest, and upper back. The bumps on the affected skin are usually red and filled with pus and may crust over. They may also become painful, tender, and itchy. Sometimes, the affected skin becomes infected. Acneiform rash may be caused by an infection or by treatment with certain drugs, including some anticancer drugs, such as  epidermal growth factor receptor (EGFR) inhibitors. Also called acneiform dermatitis and acneiform eruption.",
        "text": "A skin condition that causes small, raised, acne-like bumps to form, usually on the face, scalp, chest, and upper back. The bumps on the affected skin are usually red and filled with pus and may crust over. They may also become painful, tender, and itchy. Sometimes, the affected skin becomes infected. Acneiform rash may be caused by an infection or by treatment with certain drugs, including some anticancer drugs, such as  epidermal growth factor receptor (EGFR) inhibitors. Also called acneiform dermatitis and acneiform eruption."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 256542,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acoustic neurofibromatosis",
      "firstLetter": "a",
      "prettyUrlName": "acoustic-neurofibromatosis",
      "pronunciation": {
        "key": "(uh-KOOS-tik NOOR-oh-FY-broh-muh-TOH-sis)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/709821.mp3"
      },
      "definition": {
        "html": "A genetic condition in which tumors form on the nerves of the inner ear and cause loss of hearing and balance. Tumors may also occur in the brain and on nerves in the skull and spinal cord, and may cause loss of speech, eye movement, and the ability to swallow. Also called neurofibromatosis type 2 and NF2.",
        "text": "A genetic condition in which tumors form on the nerves of the inner ear and cause loss of hearing and balance. Tumors may also occur in the brain and on nerves in the skull and spinal cord, and may cause loss of speech, eye movement, and the ability to swallow. Also called neurofibromatosis type 2 and NF2."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 44365,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acquired immunodeficiency syndrome",
      "firstLetter": "a",
      "prettyUrlName": "acquired-immunodeficiency-syndrome",
      "pronunciation": {
        "key": "(uh-KWY-erd IH-myoo-noh-deh-FIH-shun-see SIN-drome)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/704543.mp3"
      },
      "definition": {
        "html": "A disease caused by the human immunodeficiency virus (HIV). People with acquired immunodeficiency syndrome are at an increased risk for developing certain cancers and for infections that usually occur only in individuals with a weak immune system. Also called AIDS.",
        "text": "A disease caused by the human immunodeficiency virus (HIV). People with acquired immunodeficiency syndrome are at an increased risk for developing certain cancers and for infections that usually occur only in individuals with a weak immune system. Also called AIDS."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 797028,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acquired thrombotic thrombocytopenic purpura",
      "firstLetter": "a",
      "prettyUrlName": "acquired-thrombotic-thrombocytopenic-purpura",
      "pronunciation": {
        "key": "(uh-KWY-erd throm-BAH-tik THROM-boh-sy-toh-PEE-nik PUR-pyoo-ruh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/798876.mp3"
      },
      "definition": {
        "html": "A rare condition in which blood clots form in small blood vessels throughout the body. These clots can block the flow of blood and oxygen to the body’s organs, which leads to a lower-than-normal number of platelets in the blood. Signs and symptoms of acquired thrombotic thrombocytopenic purpura include purple bruises or tiny red or purple spots on the skin, bleeding problems, anemia, fever, chest pain, nervous system problems, and kidney problems. acquired thrombotic thrombocytopenic purpura occurs when the body starts producing antibodies that block an enzyme called ADAMTS13, which is involved in blood clotting. It may be brought on by certain diseases or conditions (such as pregnancy, cancer, lupus, HIV, or other infections), certain medicines (such as chemotherapy or hormone therapy), or certain procedures (such as surgery or a stem cell transplant). acquired thrombotic thrombocytopenic purpura usually occurs in adults. Also called aTTP.",
        "text": "A rare condition in which blood clots form in small blood vessels throughout the body. These clots can block the flow of blood and oxygen to the body’s organs, which leads to a lower-than-normal number of platelets in the blood. Signs and symptoms of acquired thrombotic thrombocytopenic purpura include purple bruises or tiny red or purple spots on the skin, bleeding problems, anemia, fever, chest pain, nervous system problems, and kidney problems. acquired thrombotic thrombocytopenic purpura occurs when the body starts producing antibodies that block an enzyme called ADAMTS13, which is involved in blood clotting. It may be brought on by certain diseases or conditions (such as pregnancy, cancer, lupus, HIV, or other infections), certain medicines (such as chemotherapy or hormone therapy), or certain procedures (such as surgery or a stem cell transplant). acquired thrombotic thrombocytopenic purpura usually occurs in adults. Also called aTTP."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 44849,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acridine carboxamide",
      "firstLetter": "a",
      "prettyUrlName": "acridine-carboxamide",
      "pronunciation": {
        "key": "(A-krih-deen kar-BOK-suh-mide)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/728175.mp3"
      },
      "definition": {
        "html": "A substance being studied in the treatment of cancer. It is a type of topoisomerase inhibitor. Also called DACA.",
        "text": "A substance being studied in the treatment of cancer. It is a type of topoisomerase inhibitor. Also called DACA."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 476630,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acromegaly",
      "firstLetter": "a",
      "prettyUrlName": "acromegaly",
      "pronunciation": {
        "key": "(A-kroh-MEH-guh-lee)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/716774.mp3"
      },
      "definition": {
        "html": "A condition in which the pituitary gland makes too much growth hormone after normal growth of the skeleton is finished. This causes the bones of the hands, feet, head, and face to grow larger than normal. Acromegaly can be caused by a pituitary gland tumor.",
        "text": "A condition in which the pituitary gland makes too much growth hormone after normal growth of the skeleton is finished. This causes the bones of the hands, feet, head, and face to grow larger than normal. Acromegaly can be caused by a pituitary gland tumor."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 791380,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "Actemra",
      "firstLetter": "a",
      "prettyUrlName": "actemra",
      "pronunciation": {
        "key": "(ak-TEM-ruh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/793643.mp3"
      },
      "definition": {
        "html": "A drug used to treat severe or life-threatening cytokine release syndrome caused by a type of immunotherapy called chimeric antigen receptor (CAR) T-cell therapy. It is used in patients aged 2 years and older. Actemra is also used to treat certain types of arthritis and a condition that causes inflammation of the lining of the arteries. It is also being studied in the treatment of other conditions. Actemra binds to receptors for a protein called interleukin-6 (IL-6), which is made by white blood cells and other cells in the body. This may help lower the body’s immune response and reduce inflammation. Actemra is a type of monoclonal antibody. Also called tocilizumab.",
        "text": "A drug used to treat severe or life-threatening cytokine release syndrome caused by a type of immunotherapy called chimeric antigen receptor (CAR) T-cell therapy. It is used in patients aged 2 years and older. Actemra is also used to treat certain types of arthritis and a condition that causes inflammation of the lining of the arteries. It is also being studied in the treatment of other conditions. Actemra binds to receptors for a protein called interleukin-6 (IL-6), which is made by white blood cells and other cells in the body. This may help lower the body’s immune response and reduce inflammation. Actemra is a type of monoclonal antibody. Also called tocilizumab."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 730162,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "actinomycin D",
      "firstLetter": "a",
      "prettyUrlName": "actinomycin-d",
      "pronunciation": {
        "key": "(AK-tih-noh-MY-sin …)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/738131.mp3"
      },
      "definition": {
        "html": "A drug used to treat Ewing sarcoma, gestational trophoblastic tumor, Wilms tumor, and certain types of testicular cancer. It is also used to treat rhabdomyosarcoma in children. It is being studied in the treatment of other types of cancer. Actinomycin D comes from the bacterium Streptomyces parvulus. It damages the cell’s DNA and may kill cancer cells. It is a type of anticancer antibiotic. Also called Cosmegen and dactinomycin.",
        "text": "A drug used to treat Ewing sarcoma, gestational trophoblastic tumor, Wilms tumor, and certain types of testicular cancer. It is also used to treat rhabdomyosarcoma in children. It is being studied in the treatment of other types of cancer. Actinomycin D comes from the bacterium Streptomyces parvulus. It damages the cell’s DNA and may kill cancer cells. It is a type of anticancer antibiotic. Also called Cosmegen and dactinomycin."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 630945,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acupuncture-like transcutaneous electrical nerve stimulation",
      "firstLetter": "a",
      "prettyUrlName": "acupuncture-like-transcutaneous-electrical-nerve-stimulation",
      "pronunciation": {
        "key": "(AK-yoo-PUNK-cher-like tranz-kyoo-TAY-nee-us ee-LEK-trih-kul nerv STIM-yoo-LAY-shun)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/722575.mp3"
      },
      "definition": {
        "html": "A procedure in which mild electric currents are applied to certain acupuncture points (spots on the body where an acupuncture needle may be inserted to control pain and other symptoms) on the skin.  It is being studied in the treatment of dry mouth caused by radiation therapy for cancer. Also called ALTENS.",
        "text": "A procedure in which mild electric currents are applied to certain acupuncture points (spots on the body where an acupuncture needle may be inserted to control pain and other symptoms) on the skin.  It is being studied in the treatment of dry mouth caused by radiation therapy for cancer. Also called ALTENS."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46725,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acustimulation",
      "firstLetter": "a",
      "prettyUrlName": "acustimulation",
      "pronunciation": {
        "key": "(AK-yoo-STIM-yoo-LAY-shun)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/731752.mp3"
      },
      "definition": {
        "html": "Mild electrical stimulation of acupuncture points to control symptoms such as nausea and vomiting.",
        "text": "Mild electrical stimulation of acupuncture points to control symptoms such as nausea and vomiting."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 45145,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acute leukemia",
      "firstLetter": "a",
      "prettyUrlName": "acute-leukemia",
      "pronunciation": {
        "key": "(uh-KYOOT loo-KEE-mee-uh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/705073.mp3"
      },
      "definition": {
        "html": "A rapidly progressing cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of white blood cells to be produced and enter the blood stream.",
        "text": "A rapidly progressing cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of white blood cells to be produced and enter the blood stream."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 45586,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acute lymphoblastic leukemia",
      "firstLetter": "a",
      "prettyUrlName": "acute-lymphoblastic-leukemia",
      "pronunciation": {
        "key": "(uh-KYOOT LIM-foh-BLAS-tik loo-KEE-mee-uh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/705625.mp3"
      },
      "definition": {
        "html": "A type of leukemia (blood cancer) that comes on quickly and is fast growing. In acute lymphoblastic leukemia, there are too many lymphoblasts (immature white blood cells) in the blood and bone marrow.  Also called acute lymphocytic leukemia and ALL.",
        "text": "A type of leukemia (blood cancer) that comes on quickly and is fast growing. In acute lymphoblastic leukemia, there are too many lymphoblasts (immature white blood cells) in the blood and bone marrow.  Also called acute lymphocytic leukemia and ALL."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46332,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acute lymphocytic leukemia",
      "firstLetter": "a",
      "prettyUrlName": "acute-lymphocytic-leukemia",
      "pronunciation": {
        "key": "(uh-KYOOT LIM-foh-SIH-tik loo-KEE-mee-uh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/708555.mp3"
      },
      "definition": {
        "html": "A type of leukemia (blood cancer) that comes on quickly and is fast growing. In acute lymphocytic leukemia, there are too many lymphoblasts (immature white blood cells) in the blood and bone marrow.  Also called acute lymphoblastic leukemia and ALL.",
        "text": "A type of leukemia (blood cancer) that comes on quickly and is fast growing. In acute lymphocytic leukemia, there are too many lymphoblasts (immature white blood cells) in the blood and bone marrow.  Also called acute lymphoblastic leukemia and ALL."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 575435,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acute myeloblastic leukemia",
      "firstLetter": "a",
      "prettyUrlName": "acute-myeloblastic-leukemia",
      "pronunciation": {
        "key": "(uh-KYOOT MY-eh-loh-BLAS-tik loo-KEE-mee-uh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/721221.mp3"
      },
      "definition": {
        "html": "An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood.  Also called acute myelogenous leukemia, acute myeloid leukemia, acute nonlymphocytic leukemia, AML,  and ANLL.",
        "text": "An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood.  Also called acute myelogenous leukemia, acute myeloid leukemia, acute nonlymphocytic leukemia, AML,  and ANLL."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46757,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acute myelogenous leukemia",
      "firstLetter": "a",
      "prettyUrlName": "acute-myelogenous-leukemia",
      "pronunciation": {
        "key": "(uh-KYOOT MY-eh-LAH-jeh-nus loo-KEE-mee-uh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/710039.mp3"
      },
      "definition": {
        "html": "An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood.  Also called acute myeloblastic leukemia, acute myeloid leukemia, acute nonlymphocytic leukemia, AML,  and ANLL.",
        "text": "An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood.  Also called acute myeloblastic leukemia, acute myeloid leukemia, acute nonlymphocytic leukemia, AML,  and ANLL."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46347,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acute myeloid leukemia",
      "firstLetter": "a",
      "prettyUrlName": "acute-myeloid-leukemia",
      "pronunciation": {
        "key": "(uh-KYOOT MY-eh-loyd loo-KEE-mee-uh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/708584.mp3"
      },
      "definition": {
        "html": "An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood.  Also called acute myeloblastic leukemia, acute myelogenous leukemia, acute nonlymphocytic leukemia, AML,  and ANLL.",
        "text": "An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood.  Also called acute myeloblastic leukemia, acute myelogenous leukemia, acute nonlymphocytic leukemia, AML,  and ANLL."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 790626,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acute myeloid leukemia with myelodysplasia-related changes",
      "firstLetter": "a",
      "prettyUrlName": "acute-myeloid-leukemia-with-myelodysplasia-related-changes",
      "pronunciation": {
        "key": "(uh-KYOOT MY-eh-loyd loo-KEE-mee-uh … MY-eh-loh-dis-PLAY-zhuh-ree-LAY-ted CHAYN-jiz)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/792235.mp3"
      },
      "definition": {
        "html": "A type of acute myeloid leukemia in which at least 20% of a patient’s blood or bone marrow is myeloblasts (immature white blood cells) and the patient has one of the following conditions: 1) has had myelodysplastic syndrome (MDS) or a myelodysplastic/myeloproliferative neoplasm (MDS/MPN) before, 2) cells that have changes in certain chromosomes that are similar to those found in MDS, or 3) at least 50% of the cells (of at least two types of blood cells) are abnormal. Acute myeloid leukemia with myelodysplasia-related changes usually occurs in older adults and has a poor prognosis. Also called AML-MRC.",
        "text": "A type of acute myeloid leukemia in which at least 20% of a patient’s blood or bone marrow is myeloblasts (immature white blood cells) and the patient has one of the following conditions: 1) has had myelodysplastic syndrome (MDS) or a myelodysplastic/myeloproliferative neoplasm (MDS/MPN) before, 2) cells that have changes in certain chromosomes that are similar to those found in MDS, or 3) at least 50% of the cells (of at least two types of blood cells) are abnormal. Acute myeloid leukemia with myelodysplasia-related changes usually occurs in older adults and has a poor prognosis. Also called AML-MRC."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46215,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acute nonlymphocytic leukemia",
      "firstLetter": "a",
      "prettyUrlName": "acute-nonlymphocytic-leukemia",
      "pronunciation": {
        "key": "(uh-KYOOT non-LIM-foh-SIH-tik loo-KEE-mee-uh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/707844.mp3"
      },
      "definition": {
        "html": "An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood.  Also called acute myeloblastic leukemia, acute myelogenous leukemia, acute myeloid leukemia, AML,  and ANLL.",
        "text": "An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone marrow and blood.  Also called acute myeloblastic leukemia, acute myelogenous leukemia, acute myeloid leukemia, AML,  and ANLL."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 444957,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acute promyelocytic leukemia",
      "firstLetter": "a",
      "prettyUrlName": "acute-promyelocytic-leukemia",
      "pronunciation": {
        "key": "(uh-KYOOT proh-MY-eh-loh-SIH-tik loo-KEE-mee-uh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/714525.mp3"
      },
      "definition": {
        "html": "An aggressive (fast-growing) type of acute myeloid leukemia in which there are too many immature blood-forming cells in the blood and bone marrow. It is usually marked by an exchange of parts of chromosomes 15 and 17. Also called APL and promyelocytic leukemia.",
        "text": "An aggressive (fast-growing) type of acute myeloid leukemia in which there are too many immature blood-forming cells in the blood and bone marrow. It is usually marked by an exchange of parts of chromosomes 15 and 17. Also called APL and promyelocytic leukemia."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 700843,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "acute radiation syndrome",
      "firstLetter": "a",
      "prettyUrlName": "acute-radiation-syndrome",
      "pronunciation": {
        "key": "(uh-KYOOT RAY-dee-AY-shun SIN-drome)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/733294.mp3"
      },
      "definition": {
        "html": "Serious illness caused by being exposed to high doses of certain types of radiation, usually over a short period of time. Symptoms of acute radiation syndrome usually occur right after exposure but they may happen over time, and they may come and go. Symptoms include nausea and vomiting, diarrhea, headache, dizziness, weakness, fatigue, bleeding, hair loss, swelling, itching, and redness of the skin, and other skin problems. Very large doses of radiation may cause death. Also called acute radiation sickness, radiation poisoning, radiation sickness,  and radiation sickness syndrome.",
        "text": "Serious illness caused by being exposed to high doses of certain types of radiation, usually over a short period of time. Symptoms of acute radiation syndrome usually occur right after exposure but they may happen over time, and they may come and go. Symptoms include nausea and vomiting, diarrhea, headache, dizziness, weakness, fatigue, bleeding, hair loss, swelling, itching, and redness of the skin, and other skin problems. Very large doses of radiation may cause death. Also called acute radiation sickness, radiation poisoning, radiation sickness,  and radiation sickness syndrome."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 662449,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "ADE regimen",
      "firstLetter": "a",
      "prettyUrlName": "ade-regimen",
      "pronunciation": {
        "key": "(… REH-jih-men)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/725909.mp3"
      },
      "definition": {
        "html": "An abbreviation for a chemotherapy combination used  to treat childhood acute myeloid leukemia (AML). It includes the drugs cytarabine (Ara-C), daunorubicin hydrochloride, and etoposide phosphate. Also called ADE.",
        "text": "An abbreviation for a chemotherapy combination used  to treat childhood acute myeloid leukemia (AML). It includes the drugs cytarabine (Ara-C), daunorubicin hydrochloride, and etoposide phosphate. Also called ADE."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46216,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adenocarcinoma",
      "firstLetter": "a",
      "prettyUrlName": "adenocarcinoma",
      "pronunciation": {
        "key": "(A-deh-noh-KAR-sih-NOH-muh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/707847.mp3"
      },
      "definition": {
        "html": "Cancer that begins in glandular (secretory) cells. Glandular cells are found in tissue that lines certain internal organs and makes and releases substances in the body, such as mucus, digestive juices, or other fluids. Most cancers of the breast, pancreas, lung, prostate, and colon are adenocarcinomas.",
        "text": "Cancer that begins in glandular (secretory) cells. Glandular cells are found in tissue that lines certain internal organs and makes and releases substances in the body, such as mucus, digestive juices, or other fluids. Most cancers of the breast, pancreas, lung, prostate, and colon are adenocarcinomas."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 752832,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adenocarcinoma in situ",
      "firstLetter": "a",
      "prettyUrlName": "adenocarcinoma-in-situ",
      "pronunciation": {
        "key": "(A-deh-noh-KAR-sih-NOH-muh in SY-too)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/757943.mp3"
      },
      "definition": {
        "html": "A condition in which abnormal cells are found in the glandular tissue that lines certain internal organs, such as the uterus, cervix, lung, pancreas, and colon. Adenocarcinoma in situ, which occurs most often in the cervix, may become cancer and spread to nearby normal tissue.  Also called AIS.",
        "text": "A condition in which abnormal cells are found in the glandular tissue that lines certain internal organs, such as the uterus, cervix, lung, pancreas, and colon. Adenocarcinoma in situ, which occurs most often in the cervix, may become cancer and spread to nearby normal tissue.  Also called AIS."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46022,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adenoid cystic carcinoma",
      "firstLetter": "a",
      "prettyUrlName": "adenoid-cystic-carcinoma",
      "pronunciation": {
        "key": "(A-deh-noyd SIS-tik KAR-sih-NOH-muh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/707600.mp3"
      },
      "definition": {
        "html": "A rare type of cancer that usually begins in the salivary glands.",
        "text": "A rare type of cancer that usually begins in the salivary glands."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 46217,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adenoma",
      "firstLetter": "a",
      "prettyUrlName": "adenoma",
      "pronunciation": {
        "key": "(A-deh-NOH-muh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/707849.mp3"
      },
      "definition": {
        "html": "A tumor that is not cancer. It starts in gland-like cells of the epithelial tissue (thin layer of tissue that covers organs, glands, and other structures within the body).",
        "text": "A tumor that is not cancer. It starts in gland-like cells of the epithelial tissue (thin layer of tissue that covers organs, glands, and other structures within the body)."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 641990,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adenosarcoma",
      "firstLetter": "a",
      "prettyUrlName": "adenosarcoma",
      "pronunciation": {
        "key": "(A-den-oh-sar-KOH-muh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/722922.mp3"
      },
      "definition": {
        "html": "A tumor that is a mixture of an adenoma (a tumor that starts in the gland-like cells of epithelial tissue) and a sarcoma (a tumor that starts in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue). An example of an adenosarcoma is Wilms tumor.",
        "text": "A tumor that is a mixture of an adenoma (a tumor that starts in the gland-like cells of epithelial tissue) and a sarcoma (a tumor that starts in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue). An example of an adenosarcoma is Wilms tumor."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 797800,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adenosine deaminase-deficient severe combined immunodeficiency",
      "firstLetter": "a",
      "prettyUrlName": "adenosine-deaminase-deficient-severe-combined-immunodeficiency",
      "pronunciation": {
        "key": "(uh-DEH-nuh-seen dee-A-mih-nays-deh-FIH-shunt seh-VEER kum-BIND IH-myoo-noh-deh-FIH-shun-see)",
        "audio": null
      },
      "definition": {
        "html": "A rare, inherited disorder in which the immune system is damaged, causing a person to have a complete lack of B lymphocytes and T lymphocytes (types of white blood cells that help the body fight infection). People with adenosine deaminase-deficient severe combined immunodeficiency are at high risk of developing life-threatening viral, bacterial, and fungal infections and certain types of cancers. Signs and symptoms of adenosine deaminase-deficient severe combined immunodeficiency usually occur before 6 months of age and include serious lung infections, chronic diarrhea, skin rashes, and slow growth and development. When symptoms begin later in life, they are usually milder. Adenosine deaminase-deficient severe combined immunodeficiency is caused by mutations (changes) in the ADA gene. The ADA gene makes an enzyme called adenosine deaminase, which helps protect lymphocytes from harmful substances in the body. Also called ADA-SCID.",
        "text": "A rare, inherited disorder in which the immune system is damaged, causing a person to have a complete lack of B lymphocytes and T lymphocytes (types of white blood cells that help the body fight infection). People with adenosine deaminase-deficient severe combined immunodeficiency are at high risk of developing life-threatening viral, bacterial, and fungal infections and certain types of cancers. Signs and symptoms of adenosine deaminase-deficient severe combined immunodeficiency usually occur before 6 months of age and include serious lung infections, chronic diarrhea, skin rashes, and slow growth and development. When symptoms begin later in life, they are usually milder. Adenosine deaminase-deficient severe combined immunodeficiency is caused by mutations (changes) in the ADA gene. The ADA gene makes an enzyme called adenosine deaminase, which helps protect lymphocytes from harmful substances in the body. Also called ADA-SCID."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 476766,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adenosquamous carcinoma",
      "firstLetter": "a",
      "prettyUrlName": "adenosquamous-carcinoma",
      "pronunciation": {
        "key": "(A-deh-noh-SKWAY-mus KAR-sih-NOH-muh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/716534.mp3"
      },
      "definition": {
        "html": "A type of cancer that contains two types of cells: squamous cells (thin, flat cells that line certain organs) and gland-like cells.",
        "text": "A type of cancer that contains two types of cells: squamous cells (thin, flat cells that line certain organs) and gland-like cells."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 454697,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adjustment disorder",
      "firstLetter": "a",
      "prettyUrlName": "adjustment-disorder",
      "pronunciation": {
        "key": "(uh-JUST-ment dis-OR-der)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/714914.mp3"
      },
      "definition": {
        "html": "A condition in which a person responds to a stressful event (such as an illness, job loss, or divorce) with extreme emotions and actions that cause problems at work and home.",
        "text": "A condition in which a person responds to a stressful event (such as an illness, job loss, or divorce) with extreme emotions and actions that cause problems at work and home."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 478733,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "administration",
      "firstLetter": "a",
      "prettyUrlName": "administration",
      "pronunciation": {
        "key": "(ad-MIH-nih-STRAY-shun)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/716486.mp3"
      },
      "definition": {
        "html": "In medicine, the act of giving a treatment, such as a drug, to a patient. It can also refer to the way it is given, the dose, or how often it is given.",
        "text": "In medicine, the act of giving a treatment, such as a drug, to a patient. It can also refer to the way it is given, the dose, or how often it is given."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 430856,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adnexal mass",
      "firstLetter": "a",
      "prettyUrlName": "adnexal-mass",
      "pronunciation": {
        "key": "(ad-NEK-sul…)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/713589.mp3"
      },
      "definition": {
        "html": "A lump in tissue near the uterus, usually in the ovary or fallopian tube. Adnexal masses include ovarian cysts, ectopic (tubal) pregnancies, and benign (not cancer) or malignant (cancer) tumors.",
        "text": "A lump in tissue near the uterus, usually in the ovary or fallopian tube. Adnexal masses include ovarian cysts, ectopic (tubal) pregnancies, and benign (not cancer) or malignant (cancer) tumors."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 747093,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "ado-trastuzumab emtansine",
      "firstLetter": "a",
      "prettyUrlName": "ado-trastuzumab-emtansine",
      "pronunciation": {
        "key": "(A-doh-tras-TOO-zoo-mab em-TAN-seen)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/749859.mp3"
      },
      "definition": {
        "html": "A drug used to treat HER2-positive breast cancer. It is used in certain patients who have already been treated with an anticancer drug called trastuzumab and a type of drug called a taxane. It is also being studied in the treatment of other types of cancer. Ado-trastuzumab emtansine contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some breast cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells. Ado-trastuzumab emtansine is a type of antibody-drug conjugate. Also called Kadcyla and T-DM1.",
        "text": "A drug used to treat HER2-positive breast cancer. It is used in certain patients who have already been treated with an anticancer drug called trastuzumab and a type of drug called a taxane. It is also being studied in the treatment of other types of cancer. Ado-trastuzumab emtansine contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some breast cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells. Ado-trastuzumab emtansine is a type of antibody-drug conjugate. Also called Kadcyla and T-DM1."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 458083,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adrenal medulla",
      "firstLetter": "a",
      "prettyUrlName": "adrenal-medulla",
      "pronunciation": {
        "key": "(uh-DREE-nul meh-DOO-luh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/716552.mp3"
      },
      "definition": {
        "html": "The inner part of the adrenal gland (a small organ on top of each kidney). The adrenal medulla makes chemicals such as epinephrine (adrenaline) and norepinephrine (noradrenaline) which are involved in sending nerve signals.",
        "text": "The inner part of the adrenal gland (a small organ on top of each kidney). The adrenal medulla makes chemicals such as epinephrine (adrenaline) and norepinephrine (noradrenaline) which are involved in sending nerve signals."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 458096,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adrenalectomy",
      "firstLetter": "a",
      "prettyUrlName": "adrenalectomy",
      "pronunciation": {
        "key": "(uh-DREE-nul-EK-toh-mee)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/716952.mp3"
      },
      "definition": {
        "html": "Surgery to remove one or both adrenal glands (a small organ on top of each kidney).",
        "text": "Surgery to remove one or both adrenal glands (a small organ on top of each kidney)."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 446526,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adrenocortical carcinoma",
      "firstLetter": "a",
      "prettyUrlName": "adrenocortical-carcinoma",
      "pronunciation": {
        "key": "(uh-DREE-noh-KOR-tih-kul KAR-sih-NOH-muh)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/714554.mp3"
      },
      "definition": {
        "html": "A rare cancer that forms in the outer layer of tissue of the adrenal gland (a small organ on top of each kidney that makes steroid hormones, adrenaline, and noradrenaline to control heart rate, blood pressure, and other body functions). Also called adrenocortical cancer and cancer of the adrenal cortex.",
        "text": "A rare cancer that forms in the outer layer of tissue of the adrenal gland (a small organ on top of each kidney that makes steroid hormones, adrenaline, and noradrenaline to control heart rate, blood pressure, and other body functions). Also called adrenocortical cancer and cancer of the adrenal cortex."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 476632,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "adrenocorticotropic hormone",
      "firstLetter": "a",
      "prettyUrlName": "adrenocorticotropic-hormone",
      "pronunciation": {
        "key": "(uh-DREE-noh-KOR-tih-koh-TROH-pik HOR-mone)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/717085.mp3"
      },
      "definition": {
        "html": "A hormone made in the pituitary gland. Adrenocorticotropic hormone acts on the outer part of the adrenal gland to control its release of corticosteroid hormones. More adrenocorticotropic hormone is made during times of stress. Also called ACTH and corticotropin.",
        "text": "A hormone made in the pituitary gland. Adrenocorticotropic hormone acts on the outer part of the adrenal gland to control its release of corticosteroid hormones. More adrenocorticotropic hormone is made during times of stress. Also called ACTH and corticotropin."
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 560141,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "Adriamycin PFS",
      "firstLetter": "a",
      "prettyUrlName": "adriamycin-pfs",
      "pronunciation": {
        "key": "(AY-dree-uh-MY-sin …)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/720859.mp3"
      },
      "definition": {
        "html": "A brand name for doxorubicin hydrochloride, which is used to treat many types of cancer. Adriamycin PFS brand has been taken off the market and is no longer available. ",
        "text": "A brand name for doxorubicin hydrochloride, which is used to treat many types of cancer. Adriamycin PFS brand has been taken off the market and is no longer available. "
      },
      "relatedResources": [],
      "media": []
    },
    {
      "termId": 560142,
      "language": "en",
      "dictionary": "Cancer.gov",
      "audience": "Patient",
      "termName": "Adriamycin RDF",
      "firstLetter": "a",
      "prettyUrlName": "adriamycin-rdf",
      "pronunciation": {
        "key": "(AY-dree-uh-MY-sin …)",
        "audio": "https://nci-media-dev.cancer.gov/pdq/media/audio/720860.mp3"
      },
      "definition": {
        "html": "A brand name for doxorubicin hydrochloride, which is used to treat many types of cancer. Adriamycin RDF brand has been taken off the market and is no longer available.  ",
        "text": "A brand name for doxorubicin hydrochloride, which is used to treat many types of cancer. Adriamycin RDF brand has been taken off the market and is no longer available.  "
      },
      "relatedResources": [],
      "media": []
    }
  ],
  "links": null
}

Additional details / screenshot

• 

[zhuomingao]

This is a backend elasticsearch problem.

In the glossary index mapping settings, the lowercase_search custom analyzer needs to be modified to be:

"lowercase_search" : { "filter" : [ "lowercase", "asciifolding" ], "tokenizer" : "keyword" }

[zhuomingao]

Bob made the change to glossary loader on DEV, and I tested it works.